Immunisation programme extended to high-risk babies.The meningococcal B immunisation programme has been extended to include babies aged as young as six weeks in some areas. The MeNZB [TM] vaccine vaccine Preparation containing either killed or weakened live microorganisms or their toxins, introduced by mouth, by injection, or by nasal spray to stimulate production of antibodies against an infectious agent. is being given to children and young people up to age 20 to control the epidemic strain of meningococcal disease in New Zealand New Zealand (zē`lənd), island country (2005 est. pop. 4,035,000), 104,454 sq mi (270,534 sq km), in the S Pacific Ocean, over 1,000 mi (1,600 km) SE of Australia. The capital is Wellington; the largest city and leading port is Auckland. . From early this month, the licence was extended to allow it to be given to the high risk group of babies from six weeks to six months in the Counties Manakau, Auckland and Waitemata District Health Boards where an intensive safety monitoring Safety Monitoring of a clinical trial is conducted by an independent physician with relevant expertise. This is accomplished by review of adverse event, immediately after they occur, with timely follow-up through resolution. programme is in place. It will become available for these younger babies in the rest of the country later in the year. The immunisation programme began in Counties-Manukau DHB DHB District Health Board (New Zealand) DHB Deutscher Handball Bund (German) DHB Deutschen Hausfrauen-Bundes (Darmstadt) DHB DHB Capital Group, Inc. and some high-risk suburbs of eastern Auckland DHB and has since extended to the rest of Auckland and Northland north·land also North·land n. A region in the north of a country or an area. north  land and in the
next six months would continue to the rest of the country, Poutasi said.
More than 460,000 doses of the MeNZB vaccine have been given. Everyone
gets three doses.
|
|
||||||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion